skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Specific binding of phorbol esters to Friend erythroleukemia cells--general properties, down regulation and relationship to cell differentiation

Journal Article · · Carcinogenesis (N.Y.); (United States)

Specific and saturable binding sites for (20-/sup 3/H)phorbol 12,13-dibutyrate ((/sup 3/H)PDBu) were demonstrated in tact Friend erythroleukemia cells (FELC), in which inducible erythroid differentiation is reversibly inhibited by phorbol esters. The binding of (/sup 3/H)PDBu to intact cells was maximal within only 15 min of incubation at 37 degrees C, after which there was a gradual decrease; binding at 4 degrees C however, was alow process, requiring greater than 180 min for maximal binding. A Scatchard analysis showed that the dissociation constant for binding of (/sup 3/H)PDBu is 8.3 nM; at saturation, approximately 1.75 x 10(5) molecules of (/sup 3/H)PDBu are bound per cell. When FELC were induced to differentiate with 4mM hexameethylene bisacetamide (approximately 80% of cells were benzidine-positive), a slight decrease (10-20%) in the number of binding sites at saturation was seen, but the dissociation constant was not changed. When the cells were precultured with non-radioactive phorbol esters, a significant decrease in (/sup 3/H)PDBu binding was observed, suggesting a homologous down regulation of phorbol ester receptors. Scatchard analysis indicated that the decrease in (/sup 3/H)PDBu binding was due to a decrease in the number of binding sites and not to a change in affinity. Such specific phorbol ester binding sites might mediate a number of biochemical and biological effects of phorbol esters on FELC.

Research Organization:
International Agency for Research on Cancer, Lyon Cedex, France
OSTI ID:
6564576
Journal Information:
Carcinogenesis (N.Y.); (United States), Vol. 3:8
Country of Publication:
United States
Language:
English